Description
What is TB-500?
TB-500 is a name used for thymosin beta-4-related research materials. Commercial use of this name can refer to different sequences, including fragments, so the supplied sequence must be confirmed before applying findings from thymosin beta-4 studies.
Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.
Published study findings and evidence limits
Related-compound research — identity matters
A study of full-length thymosin beta-4 and a synthetic peptide containing its actin-binding domain reported improved wound-repair measurements in diabetic and aged mice. These findings cannot be assigned to this TB-500 listing without confirming its exact sequence and formulation. They do not establish a proven human recovery benefit.
Sources: Thymosin beta-4 and actin-binding-domain peptide in mouse wounds (2003).
Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.
For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.
Reviews
There are no reviews yet.